-
1
-
-
23744493443
-
Postoperative radiotherapy after radical prostatectomy: A randomized controlled trial (EORTC Trial 22911)
-
Bolla M, Van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC Trial 22911). Lancet 2005 366 : 572 8
-
(2005)
Lancet
, vol.366
, pp. 572-8
-
-
Bolla, M.1
Van Poppel, H.2
Collette, L.3
-
2
-
-
34547614168
-
-
on behalf or EORTC Genito-Urinary and Radiation Oncology Groups. ASCO 2007 Prostate Cancer Symposium, Orlando, Florida, February 22-24
-
Bolla M, Van Poppel H, Collette L, van der Kwast TH on behalf or EORTC Genito-Urinary and Radiation Oncology Groups. ASCO 2007 Prostate Cancer Symposium, Orlando, Florida, February 22-24, 2007
-
(2007)
-
-
Bolla, M.1
Van Poppel, H.2
Collette, L.3
Van Der Kwast, T.H.4
-
3
-
-
5444248630
-
Bicalutamide 150 MG in addition to standard care in patients with localized or locally advanced prostate cancer. results from the second analysis of the early prostate cancer program at median follow up of 5.4 years
-
Wirth MP, See WA, McLeod DG et al. Bicalutamide 150 MG in addition to standard care in patients with localized or locally advanced prostate cancer. results from the second analysis of the early prostate cancer program at median follow up of 5.4 years. J Urol 2004 172 : 1865 70
-
(2004)
J Urol
, vol.172
, pp. 1865-70
-
-
Wirth, M.P.1
See, W.A.2
McLeod, D.G.3
-
4
-
-
34547619333
-
-
FDA Statement. Pfizer stops all torcetrapib clinical trials in interest of patient safety. Available at. Accessed May 2007
-
FDA Statement. Pfizer stops all torcetrapib clinical trials in interest of patient safety December 3, 2006 Available at http://www.fda.gov/bbs/topics/ NEWS/2006/NEW01514.html Accessed May 2007
-
(2006)
-
-
-
5
-
-
0023243140
-
Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathologic stage II testicular cancer
-
Williams SD, Stablein DM, Einhorn LH et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathologic stage II testicular cancer. N Eng J Med 1987 317 : 1433 8
-
(1987)
N Eng J Med
, vol.317
, pp. 1433-8
-
-
Williams, S.D.1
Stablein, D.M.2
Einhorn, L.H.3
-
6
-
-
11144355828
-
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
-
Stephenson AJ, Shariat SF, Zelefsky MJ et al. salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004 291 : 1325 32
-
(2004)
JAMA
, vol.291
, pp. 1325-32
-
-
Stephenson, A.J.1
Shariat, S.F.2
Zelefsky, M.J.3
-
7
-
-
33746736194
-
Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy. evaluation of prognostic factors and creation of a prognostic scoring system
-
Buskirk SJ, Pisansly TM, Schild SE et al. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy. evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 2006 176 : 985 90
-
(2006)
J Urol
, vol.176
, pp. 985-90
-
-
Buskirk, S.J.1
Pisansly, T.M.2
Schild, S.E.3
-
8
-
-
33751018522
-
Adjuvant radiotherapy for pathologically advanced prostate cancer
-
Thompson I, Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer. JAMA 2006 296 : 2329 35
-
(2006)
JAMA
, vol.296
, pp. 2329-35
-
-
Thompson, I.1
Tangen, C.M.2
Paradelo, J.3
-
9
-
-
15044353361
-
Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy
-
Eggener SE, Roehl KA, Smith ND et al. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy. J Urol 2005 173 : 1150 5
-
(2005)
J Urol
, vol.173
, pp. 1150-5
-
-
Eggener, S.E.1
Roehl, K.A.2
Smith, N.D.3
|